Related Articles
Joint detection of multiple immunohistochemical indices and clinical significance in breast cancer
Prognostic utility of fluorescence in situ hybridization for determining HER2 gene amplification in breast cancer
Alterations in three biomarkers (estrogen receptor, progesterone receptor and human epidermal growth factor 2) and the Ki67 index between primary and metastatic breast cancer lesions
Co-expressed type of ER and HER2 protein as a predictive factor in determining resistance to antiestrogen therapy in patients with ER-positive and HER2-positive breast cancer
Extended trastuzumab therapy improves the survival of HER2‑positive breast cancer patients following surgery and radiotherapy for brain metastases